Clinical Trial Update: Phase 1 Study to Evaluate the Pharmacokinetics and Safety Following SC Administration of DWJ108J in Patients With Prostate Cancer [Phase 1]

View source ↗

Summary

This clinical trial update outlines a Phase 1 study to evaluate the pharmacokinetics and safety of DWJ108J administered subcutaneously in patients with prostate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• DWJ108J

Snippet

Sponsor: Daewoong Pharmaceutical Co. LTD. | Conditions: Prostate Cancer | Phase 1 | Status: UNKNOWN